Related Experiment Video
Updated: Jul 4, 2026
07:55
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Recent progress in the genomics of soft tissue sarcomas
Anthony P Conley1, Jonathan Trent, Wei Zhang
1Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Current Opinion in Oncology
|June 6, 2008
Summary
Genomic analysis reveals distinct subtypes of soft tissue sarcomas, identifying new diagnostic markers and prognostic tools. These advances hold promise for improving patient care and treatment strategies.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Soft tissue sarcomas are rare, diverse tumors with slow progress in diagnostics and therapeutics.
- Genomic analysis offers potential for new gene signatures, prognostic predictors, and diagnostic classification.
Purpose of the Study:
- To explore how genomic profiling can advance the understanding and treatment of soft tissue sarcomas.
- To identify novel diagnostic markers, prognostic tools, and therapeutic targets through genomic analysis.
Main Methods:
- Genomic profiling of various soft tissue sarcoma subtypes.
- Application of statistical methods like support vector machine analysis.
- Identification of key molecular pathways and gene signatures.
Main Results:
- Genomic diversity correlates with sarcoma subtypes; pleomorphic sarcomas can be distinguished using specific analyses.
- Identified significant pathways (retinoic acid, receptor tyrosine kinases) and gene sets for Ewing's sarcoma.
- Developed a paired gene analysis distinguishing gastrointestinal stromal tumors from leiomyosarcomas with high accuracy.
Conclusions:
- Functional genomics can lead to improved diagnostic techniques and biomarkers for minimal residual disease detection.
- Genomic approaches offer potential for enhanced prognostic tools and improved standards of care for sarcoma patients.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...